Skip to content

Efficacy of Shothaghna Lepa and Transdermal Patch in Sandhigata Vata

Comparative Clinical Study To Evaluate The Efficacy Of Shothaghna Lepa And Shothaghna Transdermal Patch In The Management Of Sandhigata Vata (Sama Avastha)- A Randomized Controlled Trial - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/104692
Enrollment
30
Registered
2026-02-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M199- Osteoarthritis, unspecified site

Interventions

None listed

Sponsors

Dr Deependra Karnawat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient fulfilling the signs and symptoms of samsandhigatvata Vata Patient of all socio-economic group. Patient who is willing to give written consent.

Exclusion criteria

Exclusion criteria: Patient having known allergic reactions to the components of the Shothaghna Lepa. Patient having other joint diseases like Psoriatic Arthritis, Gout Arthritis and Rheumatoid Arthritis. Patient with Pregnancy and lactating women.

Design outcomes

Primary

MeasureTime frame
Reduction in Sandhishotha (Swelling)Timepoint: 0th day , 7th day, 14th day

Secondary

MeasureTime frame
Improvement in pain, stiffness, and patient complianceTimepoint: 0th day, 7th day, 14th day

Countries

India

Contacts

Public ContactDr Dinesh B patil

Parul Institute of Ayurved and Research

dr.dineshpatil3@gmail.com9039764509

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026